Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

2013421 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 14, Issue 10, pp. 953-961

Field-Weighted Citation Impact: 32.86